Harpoon Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 8.3 million compared to USD 5.84 million a year ago. Net loss was USD 17.35 million compared to USD 16.76 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.52 a year ago.
For the six months, revenue was USD 14.21 million compared to USD 14.85 million a year ago. Net loss was USD 37.67 million compared to USD 78.49 million a year ago. Basic loss per share from continuing operations was USD 1.14 compared to USD 2.45 a year ago.